Trial Profile
Double-Blind, Randomized, Placebo-Controlled, Phase 2 Safety And Efficacy Trial Of Multistem In Adults With Ischemic Stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2023
Price :
$35
*
At a glance
- Drugs Invimestrocel (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms MASTERS-1
- Sponsors Athersys
- 09 Jan 2023 According to Athersys media release, in November 2022 the company conducted a meeting of Key Opinion Leaders (KOL's) to discuss the potential changes to given clinical findings from this study.
- 15 Nov 2022 According to a Athersys media release, the company is collaborating with The University of Texas Health Science Center at Houston
- 14 Mar 2019 According to a Athersys media release, this study has been selected for presentation at the American Thoracic Society International Conference in May 2019.